| Literature DB >> 25392683 |
Dee H Wu1, Chance L Matthiesen2, Anthony M Alleman3, Aaron L Fournier3, Tyler C Gunter2.
Abstract
This work examines the feasibility and implementation of information service-orientated architecture (ISOA) on an emergent literature domain of human papillomavirus, head and neck cancer, and imaging. From this work, we examine the impact of cancer informatics and generate a full set of summarizing clinical pearls. Additionally, we describe how such an ISOA creates potential benefits in informatics education, enhancing utility for creating enduring digital content in this clinical domain.Entities:
Keywords: cancer informatics; head and neck cancer; human papillomavirus; imaging; literature management
Year: 2014 PMID: 25392683 PMCID: PMC4216039 DOI: 10.4137/CIN.S13884
Source DB: PubMed Journal: Cancer Inform ISSN: 1176-9351
Evaluation instrument used by physician mentors.
| I. Item Questions | |
|---|---|
| 1. Item Information Retrieval | Was the Information in the item* appropriate to extract/retrieve from the article? (NOTE: does not cover feasibility/practically – see #2 below) |
| 2. Item Practically | Is the item applicable to current clinical situations? |
| 3. Item Extraction | Did the ‘curator’ reduce the material to an appropriate level? (Note: consider the curator’s derivation, inference, deduction) |
| 4. Item Accuracy | Does the description of the reduced text still represent the author’s original idea (actual text)? (Note: precision and representation stand in) |
| 5. Item Educational Value | Rank the educational value or benefit of this item: |
| 6. Category Accuracy | How accurately was the article Categorized (As the main topic) |
| 7. Subcategory Accuracy | How accurately was the topic placed in the Subcategory |
| 8. Category Multi Accuracy | If item was placed in multiple categories (more than one topic) was this accurately done ? (Yes, No, NA) If no, elaborate |
| 9. Category Introduction (adding new category) | Did ‘trainee’ add a new topic to the knowledge tree? (Yes, no) If so, rank its value to the knowledge tree below: |
| 10. Categorization Education Value | Is this topic useful for the education of a trainee? |
| 11. Article Importance | Rank the overall level of the article Importance to the literature |
| 12. Educational Value for this Article | Rank the overall level of the article’s educational benefit to the student level of Importance |
Note: The 12 questions are broken down into three different groupings: (1) item-level questions, (2) topic-level questions, and (3) article-level questions.
Figure 1Our Clinical Classification Schema, which was used by trainees to classify the items they extracted from the 20 articles into the proper place.
Clinical pearls generated from this LIMES study.
| RADIOLOGIST (AND FORMER OTORHINOGOLOGY SURGEON) CLINICAL PEARLS | RADIATION ONCOLOGIST CLINICAL PEARLS |
|---|---|
| HPV-positivity is associated with cystic or necrotic lymph node metastases on imaging, and imaging may allow for determination of HPV status and prognosis (Corey 2012). | Older techniques such as ultrasound and CT are becoming less popular in favor of the more sensitive and specific PET/CT scan (Corey 2012) & (Hamoir 2012). The proper incorporation of imaging is essential to ensure accurate staging (Corey 2012). |
| Cystic lymph node metastases are frequently associated with HPV-positive squamous cell carcinoma with primary tumor located in Waldeyer’s ring. These lymph nodes have a characteristic appearance on imaging that distinguishes them from solid metastases with necrotic degeneration. This information is especially helpful when searching for presenting symptom (Goldenberg 2008). | MRI can also be incorporated, but is debatable as to the true benefit in all cases (Hamoir 2012). |
| Imaging consistently shows bulky large and multiloculated lymph nodes in the neck (Goldenburg 2008). | |
| Cystic lymph nodes are associated with HPV head and neck squamous cell carcinoma and have a distinct appearance on imaging. Contrast-enhanced PET/CT offers the greatest accuracy in the N staging of head and neck squamous cell. | Most of these tumors are centered in the oropharynx, or base of tongue and tonsil, but can also be found in the oral cavity, nasopharynx, and larynx (Corey 2012) & (Strojan 2013). However with reduced frequency in the larynx and nasopharynx. |
| HPV-positive tumors tended to be well demarcated, while HPV-negative tumors demonstrated ill-defined borders with increased propensity to invade surrounding muscle. The index of suspicion for HPV-positive squamous cell carcinoma of the oropharynx should be high in the setting of a cystic neck mass (Cantrell 2013). | |
| PET/CT has no proven benefit over CT alone in detecting residual disease in locally advanced HNSCC in unselected patients. There is, however, a benefit in high-risk patients, such as those with HPV-negative disease, positive tobacco history, and nonoropharyngeal cancer (Moeller 2009). | |
| PET/CT and CT are both useful in predicting disease-specific survival in high-risk HNSCC patients. These modalities are less helpful in low-risk patients and patients with distant metastases (Moeller 2010). | |
| Contralateral neck metastases in the setting of a small primary should raise the index of suspicion for a synchronous tumor. PET scanning is helpful in identification of primary tumors as well as searching for other metastases (Roeser 2010). | |
| Head and neck squamous cell carcinoma may best be addressed with consideration to different etiologies and mechanisms of carcinogenesis, as well as using novel techniques such as molecular imaging to guide therapy and evaluate response. HPV-positivity in particular is an important prognostic biomarker, predicting disease behavior and response to therapy (Pryor 2011). | |
| Biomarkers provide an effective way to stratify patients to different treatment modalities. Patients with aggressive biologic features such as aneuploidy, high serum VEGF, and infiltrating histologic pattern may best be treated with chemoradiation, while those with less-aggressive biologic features may best be treated with surgery (Wolf 2007). | |
| A negative post-treatment PET/CT scan may identify patients who require less-intensive surveillance for recurrence in HNSCC. HPV-positivity increases the accuracy of this finding (Zhang 2011). | |
| Hypoxia imaging may provide a way to stratify patients into those who may require hypoxia modification strategies to improve tumor control (Pryor 2011). | |
| PET scanning shows increased accuracy in the assessment of response to chemoradiotherapy in the setting of locally advanced HNSCC (Pryor 2011). | |
| Techniques such as FLT-PET which indicate cellular proliferation may be helpful in determining response early in treatment (Pryor 2011). | |
| HPV-positivity is associated with cystic or necrotic lymph node metastases on imaging, and imaging may allow for determination of HPV status and prognosis (Corey 2012). | Patients being treated for such HPV-positive disease originating in the oropharynx often have a better response to therapy, which is suggestive of improved outcomes (Chen 2013). |
| Second primary cancers in the setting of HNSCC are an important consideration in prognosis as well as treatment. Their management may affect the treatment of the HNSCC and should be addressed first (Myers 2010). | There are many different presentations of head and neck cancer and other rare entities that must be considered in the differential diagnosis (Corey 2012). |
| Cancers with an unknown primary present a difficult scenario regarding workup and treatment. Treatment should be tailored to the individual, with different regimens indicated based on extent of disease and HPV-positivity (Strojan 2013). | A careful history and physical examination eliciting an absence of smoking exposure and younger patient age are immediately suggestive of HPV infection (Chen 2013). |
| HPV-positive head and neck cancers regress in size more rapidly during the early phase of treatment when compared to HPV-negative head and neck cancers. This suggests that the traditional dose of 70 Gy may be too high in this population, and individualized treatment plans may help to decrease unnecessary toxicity (Chen 2013). | The response to therapy for HPV-positive tumors in these locations appears to be more variable than when primary in the oropharynx (this also RELATES TO IMAGING) (Corey 2012). |
| Further understanding of these tumors and perceived increased response to treatment could potentially open the avenue to de-escalate treatment therapy, potentially reducing treatment toxicity and long-term morbidity for survivors (Chen 2013). | |
| HPV-associated HNSCC is more responsive to therapy and less likely to develop subsequent malignancies than HPV-negative HNSCC. It typically presents in younger, non-smoking individuals at the tonsil or at the base of tongue. Primary tumors are typically small, with large cystic lymph nodes. Histologically, they are non-keratinizing and basaloid (Pryor 2011). | The response of all HPV-positive cancers to chemoradiation appears to be more responsive than non-HPV cancers, although a range of responses are noted (response to IMRT, Chen 2013). |
Figure 2The means and standard deviations of the scores for the eight numerically represented questions. Note that these values are aggregated across all physicians and trainees.
Figure 3Selected trend values between the two trainees on item information retrieval, item practicality, item education value and classification education value.
Approximate incidence of HPV+/− HNSCC/oropharyngeal cancer both worldwide and in the US as estimated from publication reports.2
| HPV+ HNSCC | 150,000 |
| HPV− HNSCC | 450,000 |
| HPV+ oropharyngeal cancer | 25,358 |
| HPV− oropharyngeal cancer | 14,892 |